2nd Quarter - Report

WINNING STRATEGIES WASHINGTON for NATIONAL FRAGILE X FOUNDATION

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation directly impacting disability and rare disease communities; Issues around the funding of rare disease research

LobbyistCovered position, as disclosed
ELIZABETH CONNOLLY Assistant Director of Public Health, Office of National Drug Control Policy
MICHAEL A MEROLA Deputy CoS, Sen. Torricelli
DONNA MULLINS CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding for Fragile X and related initiates

LobbyistCovered position, as disclosed
ELIZABETH CONNOLLY Assistant Director of Public Health, Office of National Drug Control Policy
MICHAEL A MEROLA Deputy CoS, Sen. Torricelli
DONNA MULLINS CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.